UB Paderborn / Katalog / Suche / in CDI

Prospective Randomized Phase II Trial of a Single Early Intravesical Instillation of Pirarubicin (THP) in the Prevention of Bladder Recurrence After Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: The THP Monotherapy Study Group Trial

Journal of clinical oncology, 2013-04, Vol.31 (11), p.1422-1427

2013

Volltextzugriff (PDF)

Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan

International journal of clinical oncology, 2020-05, Vol.25 (5), p.912-920

2020

Volltextzugriff (PDF)

Impact of Nerve-Sparing Status on Positive Surgical Margin Location and Biochemical Recurrence in Patients with Prostate Cancer Post Radical Prostatectomy

Annals of surgical oncology, 2021-09, Vol.28 (9), p.5341-5348

2021

Volltextzugriff (PDF)

Increased sialidase activity in serum of cancer patients: Identification of sialidase and inhibitor activities in human serum

Cancer science, 2015-04, Vol.106 (4), p.383-389

2015

Volltextzugriff (PDF)

Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma

International journal of urology, 2016-05, Vol.23 (5), p.378-384

2016

Volltextzugriff (PDF)

ASC-J9 Suppresses Castration-Resistant Prostate Cancer Growth through Degradation of Full-length and Splice Variant Androgen Receptors

Neoplasia (New York, N.Y.), 2012, Vol.14 (1), p.74-IN12

2012

Volltextzugriff (PDF)

Efficacy of early ureteral ligation on prevention of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: a prospective single-arm multicenter clinical trial

Japanese journal of clinical oncology, 2017-09, Vol.47 (9), p.870-875

2017

Volltextzugriff (PDF)

Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone‐sensitive prostate cancer with Gleason score ≥8

International journal of urology, 2022-04, Vol.29 (4), p.324-331

2022

Volltextzugriff (PDF)

Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: a propensity score-matched analysis

International journal of clinical oncology, 2015-10, Vol.20 (5), p.1018-1025

2015

Volltextzugriff (PDF)

Reassessment of the risk factors for biochemical recurrence in D'Amico intermediate-risk prostate cancer treated using radical prostatectomy

International journal of urology, 2015-11, Vol.22 (11), p.1029-1035

2015

Volltextzugriff (PDF)

Transient increase in lactate dehydrogenase after granulocyte colony‐stimulating factor administration during chemotherapy in a patient with advanced seminoma

IJU case reports, 2019-01, Vol.2 (1), p.34-36

2019

Volltextzugriff (PDF)

Is pelvic lymph node dissection required at radical prostatectomy for low-risk prostate cancer?

International journal of urology, 2013-11, Vol.20 (11), p.1092-1096

2013

Volltextzugriff (PDF)

Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trial

Japanese journal of clinical oncology, 2013-11, Vol.43 (11), p.1139-1144

2013

Volltextzugriff (PDF)

Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy

International journal of clinical oncology, 2015-02, Vol.20 (1), p.176-181

2015

Volltextzugriff (PDF)

Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy

Cancer medicine (Malden, MA), 2019-11, Vol.8 (15), p.6566-6577

2019

Volltextzugriff (PDF)

Clinical implications of serum N‐glycan profiling as a diagnostic and prognostic biomarker in germ‐cell tumors

Cancer medicine (Malden, MA), 2017-04, Vol.6 (4), p.739-748

2017

Volltextzugriff (PDF)

Patient‐reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial

Cancer medicine (Malden, MA), 2021-05, Vol.10 (10), p.3240-3248

2021

Volltextzugriff (PDF)

Quality of life after radical prostatectomy in elderly men

International journal of urology, 2009-10, Vol.16 (10), p.813-819

2009

Volltextzugriff (PDF)

The Relationships Between Preoperative Sexual Desire and Quality of Life Following Radical Prostatectomy: A 5‐Year Follow‐Up Study

Journal of sexual medicine, 2012-09, Vol.9 (9), p.2448-2456

2012

Volltextzugriff (PDF)

Quality of life after radical prostatectomy in Japanese men: A 5-Year follow up study

International journal of urology, 2009-01, Vol.16 (1), p.75-81

2009

Volltextzugriff (PDF)

Efficiency of pretreatment risk stratification systems for prostate cancer in a Japanese population treated with radical prostatectomy

International journal of urology, 2015-01, Vol.22 (1), p.70-73

2015

Volltextzugriff (PDF)

Psychological distress in Japanese men with localized prostate cancer

International journal of urology, 2007-10, Vol.14 (10), p.924-929

2007

Volltextzugriff (PDF)

Are pathological and oncological outcomes of elderly men treated with radical prostatectomy worse than those of younger men? Matched-pair analysis between patients aged <70 and ≥70 years

Japanese journal of clinical oncology, 2014-06, Vol.44 (6), p.587-592

2014

Volltextzugriff (PDF)

Changes in indications and oncological outcomes of radical prostatectomy after 2000--data from 1268 Japanese patients treated with radical prostatectomy between 2000 and 2009

Japanese journal of clinical oncology, 2013-08, Vol.43 (8), p.821-826

2013

Volltextzugriff (PDF)

Pathological and oncological outcomes of elderly men with clinically localized prostate cancer

Japanese journal of clinical oncology, 2013-12, Vol.43 (12), p.1238-1242

2013

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Prospective Randomized Phase II Trial of a Single Early Intravesical Instillation of Pirarubicin (THP) in the Prevention of Bladder Recurrence After Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: The THP Monotherapy Study Group Trial

Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan

Impact of Nerve-Sparing Status on Positive Surgical Margin Location and Biochemical Recurrence in Patients with Prostate Cancer Post Radical Prostatectomy

Increased sialidase activity in serum of cancer patients: Identification of sialidase and inhibitor activities in human serum

Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma

ASC-J9 Suppresses Castration-Resistant Prostate Cancer Growth through Degradation of Full-length and Splice Variant Androgen Receptors

Efficacy of early ureteral ligation on prevention of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: a prospective single-arm multicenter clinical trial

Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone‐sensitive prostate cancer with Gleason score ≥8

Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: a propensity score-matched analysis

Reassessment of the risk factors for biochemical recurrence in D'Amico intermediate-risk prostate cancer treated using radical prostatectomy

Transient increase in lactate dehydrogenase after granulocyte colony‐stimulating factor administration during chemotherapy in a patient with advanced seminoma

Is pelvic lymph node dissection required at radical prostatectomy for low-risk prostate cancer?

Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trial

Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy

Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy

Clinical implications of serum N‐glycan profiling as a diagnostic and prognostic biomarker in germ‐cell tumors

Patient‐reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial

Quality of life after radical prostatectomy in elderly men

The Relationships Between Preoperative Sexual Desire and Quality of Life Following Radical Prostatectomy: A 5‐Year Follow‐Up Study

Quality of life after radical prostatectomy in Japanese men: A 5-Year follow up study

Efficiency of pretreatment risk stratification systems for prostate cancer in a Japanese population treated with radical prostatectomy

Psychological distress in Japanese men with localized prostate cancer

Are pathological and oncological outcomes of elderly men treated with radical prostatectomy worse than those of younger men? Matched-pair analysis between patients aged <70 and ≥70 years

Changes in indications and oncological outcomes of radical prostatectomy after 2000--data from 1268 Japanese patients treated with radical prostatectomy between 2000 and 2009

Pathological and oncological outcomes of elderly men with clinically localized prostate cancer

Suchergebnisse filtern